Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 275

1.

Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.

Leucht S, Pitschel-Walz G, Engel RR, Kissling W.

Am J Psychiatry. 2002 Feb;159(2):180-90.

PMID:
11823257
[PubMed - indexed for MEDLINE]
2.

Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials.

Leucht S.

Int J Neuropsychopharmacol. 2004 Mar;7 Suppl 1:S15-20.

PMID:
14972080
[PubMed - indexed for MEDLINE]
3.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
[PubMed - indexed for MEDLINE]
4.

How do we choose between atypical antipsychotics? The advantages of amisulpride.

Mortimer AM.

Int J Neuropsychopharmacol. 2004 Mar;7 Suppl 1:S21-5. Review.

PMID:
14972081
[PubMed - indexed for MEDLINE]
5.

Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.

Freeman HL.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S11-7. Review.

PMID:
9218163
[PubMed - indexed for MEDLINE]
6.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
7.

Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?

Blin O.

Encephale. 2000 Oct;26 Spec No 1:7-11. Review. English, French.

PMID:
11294060
[PubMed - indexed for MEDLINE]
8.

Amisulpride: a review of its use in the management of schizophrenia.

McKeage K, Plosker GL.

CNS Drugs. 2004;18(13):933-56. Review.

PMID:
15521794
[PubMed - indexed for MEDLINE]
9.

Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial.

Bhowmick S, Hazra A, Ghosh M.

Aust N Z J Psychiatry. 2010 Mar;44(3):237-42. doi: 10.3109/00048670903487134.

PMID:
20050717
[PubMed - indexed for MEDLINE]
10.

Amisulpride versus risperidone in the treatment of schizophrenic patients: a double-blind pilot study in Taiwan.

Hwang TJ, Lee SM, Sun HJ, Lin HN, Tsai SJ, Lee YC, Chen YS.

J Formos Med Assoc. 2003 Jan;102(1):30-6.

PMID:
12684609
[PubMed - indexed for MEDLINE]
11.

Clinical update on amisulpride in deficit schizophrenia.

Rein W, Turjanski S.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S19-27. Review.

PMID:
9218164
[PubMed - indexed for MEDLINE]
12.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

PMID:
16707074
[PubMed - indexed for MEDLINE]
Free Article
13.

[Evaluation of efficacy and tolerance of amisulpride in treatment of schizophrenic psychoses].

Chabannes JP, Pelissolo A, Farah S, Gerard D.

Encephale. 1998 Jul-Aug;24(4):386-92. French.

PMID:
9809244
[PubMed - indexed for MEDLINE]
14.

A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients.

Riedel M, Eich FX, Möller HJ.

Eur Psychiatry. 2009 Apr;24(3):149-53. doi: 10.1016/j.eurpsy.2008.10.005. Epub 2008 Dec 13.

PMID:
19070995
[PubMed - indexed for MEDLINE]
15.

Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group.

Danion JM, Rein W, Fleurot O.

Am J Psychiatry. 1999 Apr;156(4):610-6.

PMID:
10200742
[PubMed - indexed for MEDLINE]
16.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
17.

Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.

Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B.

Am J Psychiatry. 2001 Apr;158(4):518-26.

PMID:
11282684
[PubMed - indexed for MEDLINE]
18.

A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.

Mortimer A, Martin S, Lôo H, Peuskens J; SOLIANOL Sudy Group.

Int Clin Psychopharmacol. 2004 Mar;19(2):63-9.

PMID:
15076013
[PubMed - indexed for MEDLINE]
19.

Amisulpride: a review of its use in the management of schizophrenia.

Curran MP, Perry CM.

Drugs. 2001;61(14):2123-50. Review.

PMID:
11735643
[PubMed - indexed for MEDLINE]
20.

Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials.

Tuunainen A, Wahlbeck K, Gilbody S.

Schizophr Res. 2002 Jul 1;56(1-2):1-10. Review.

PMID:
12084413
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk